Navigation Links
BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza
Date:10/13/2009

timicrobials is $6 billion and some of the solutions historically deployed need to be upgraded to improved science such as BIOSAFE's. Our product is non-leaching, has no volatile organic compounds (VOCs), heavy metals, or polychlorinated phenols. We provide significant benefits in manufacturability thereby reducing hurdles to adoption, while lowering the ultimate costs in the process."

Cantel's President and CEO, Andrew Krakauer explained, "BIOSAFE is an important component of our strategic plans to expand our liquid chemical germicide business and invest more aggressively in research & development. Given the unique performance, manufacturability, and cost advantages of this additive, Cantel has embarked on a number of internal R&D initiatives to incorporate BIOSAFE into a variety of its other products." Mr. Krakauer continued, "We have invested significant dollars, resources, and time towards this goal and it has been a fantastic cross-divisional effort that demonstrates how we are gaining leverage from the expertise in our different companies."

Within the United States, the sale of facemasks treated with BIOSAFE antimicrobial for medical applications is subject to a 510(k) clearance by the U.S. Food and Drug Administration. At this time the Company is awaiting publication of the latest revision of the FDA Guidance Document pertaining to antimicrobial treatments of medical devices prior to the filing of its application. The Company is in the process of submitting an application with the U.S. Environmental Protection Agency covering the sale of treated masks in the United States for non-medical applications.

About BIOSAFE, Inc.

Pittsburgh-based BIOSAFE, Inc., has been funded by Pittsburgh Life Sciences Greenhouse, Innovation Works, and Bluetree Allied Angels, manufactures and sells an antimicrobial polymer, HM 4100. HM4100 is effective in defending against bacteria, fungi (mold and mildew), yeas
'/>"/>

SOURCE BIOSAFE, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Hampshire Rx Card Launching Statewide
2. Lilly Advances Second Alzheimers Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
3. Cantel Medicals Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
4. Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis
5. HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV
6. Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says
7. Researchers Find High-Dose Therapy for Liver Disease Not Effective
8. Clinical Study Proves Pollogens TriPollar(TM) Radio Frequency Technology is Effective in the Treatment of Stretch Marks
9. New Research Shows Effectiveness of Stereotactic Body Radiotherapy for Spinal Tumors
10. National Cancer Institute Research Identifies Unique Mechanism of Brostallicins Anti-Tumor Effectiveness
11. Reliv Internationals GlucAffect(TM) Proven Effective in Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  Cleveland Clinic President Wael Barsoum ... last month that industry is compelled to adopt declining ... the efficiencies—and develop the transformational innovations -- required to ... were preceded by Doug Kohrs , past President ... who stressed that industry must add "episode of care," ...
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
(Date:7/30/2015)... Takeda Pharmaceutical Company Limited ("Takeda") today announced ... post-marketing commitment and submissions of data to regulatory ... Cancer Risk Characterization Study , a large (n= ... four European countries, for pioglitazone containing medicines, including ... of follow-up. Findings demonstrate that there is no ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... PDS Biotechnology Corporation today,announced that the company ... the US,National Cancer Institute,s Nanotechnology Characterization Lab ... to filing of,the Investigational New Drug Application. ... biological studies on behalf of the company ...
... Dendreon Corporation (Nasdaq:,DNDN) today will present a summary ... investigational active cellular immunotherapy, at the,Chemotherapy Foundation Symposium ... data from two clinical trials, highlights the safety,profile, ... patients with,HER2/neu-positive cancer who have failed standard therapy., ...
Cached Medicine Technology:PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 2Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 2Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 3Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 4
(Date:7/30/2015)... , ... July 30, 2015 , ... As more hospitals ... activity of recruiting patients becomes a serious challenge. Because of growing competition, it ... patients within the local community. , The team at Wound Care Advantage ...
(Date:7/30/2015)... ... July 30, 2015 , ... In an effort to provide the twenty ... making a change in his practice. , The decision will also allow him to ... Aggarwal will be transferring his in-patient admissions to the hospitalists at East Liverpool City ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zaca ... on the go. With no water needed, the refreshing berry-flavored tablets are the ... to get the natural ingredients that may help with body detoxification, protection and ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... the recipient of three awards in the Service Industry Advertising Awards 12th annual ... Choptank Transport, KRM Development Corporation and University of Maryland Shore Regional Health. , ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... one of the largest, family-owned low cost service and repair companies. For 35 ... as well as growing their company to meet the demands of the changing ...
Breaking Medicine News(10 mins):Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3
... children are to be weighed, measured and interviewed regarding ... //the growing menace of childhood obesity. The Australian Health ... aged between 7 and 15, are either overweight or ... of heart disease and diabetes. Federal Health Minister Tony ...
... surgeon and a researcher at the children hospital of ... dose anti rejection protocol //has appreciably improved the outcomes ... by Rakesh Sindhi, MD, Co-Director of Pediatric Transplantation, and ... new protocol reduces drug doses and eliminates steroids altogether ...
... up with a new preventive strategy to fight childhood obesity.// ... concern for both the parent and the society. In the ... a program in Meade County, Ky to fight childhood obesity. ... researchers are planning to launch the new program among the ...
... According to the scientist from the Victorian Breast Cancer Research ... have undergone some mutation give rise to the most aggressive ... Hall Institute researchers were working on mouse models when they ... for the female hormones oestrogen or progesterone. This characteristic is ...
... revealed that many popular breakfast cereals contain high levels of ... brands of cereals that were checked for sugar, salt and ... than three-quarters had a high level of sugars, while a ... had high level of saturated fat. ...
... recent announcements by Health Minister, Tony Abbott, to tackle ... has failed to impress AMA President Mukesh// Haikerwal. The ... so that problem can be tackled more effectively. ... new ministerial taskforce for an anti-obesity campaign involving industry ...
Cached Medicine News:Health News:Low Dose Anti Rejection Protocol Helps Intestinal Transplant Recipients 2Health News:New Preventive Strategy to Fight Childhood Obesity 2Health News:Mutation in Breast Stem Cells Lead to Breast Cancer 2
... Transfer an Entire Column of a 384 Well ... throughput with 384 well plates, you need a ... spacing. Thats exactly what you get with our ... software (see Impact/Impact2), this innovation was specifically designed ...
... CS and Alliance Catheter Delivery ... the introduction of catheters or ... from a superior approach. These ... outstanding peel-away introducer performance with ...
The AXIUS™ Blower/Mister provides controlled delivery of CO2 and saline to improve visibility during anastomosis....
... Biliary Self-Expanding Stent System combines low-profile, high radial ... .018" guide wire compatible stent system provides 6F ... diameters (5.0 - 10.0 mm). Now, with longer ... in five stent lengths (28, 38, 56, 80 ...
Medicine Products: